US2014018328A1PendingUtilityA1
Clear, Greaseless Skin Care Compositions
Est. expirySep 25, 2022(expired)· nominal 20-yr term from priority
A61K 31/618A61K 47/34A61K 31/125A61K 31/07A61K 31/165A61K 31/045A61K 9/06A61K 9/0014
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to compositions including anhydrous compositions which include a dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products which may include retinoic acid, retinoic acid derivatives, retinal, retinol and/or retinyl esters, and methods of making, storing, and using such compositions.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A topical analgesic composition comprising at least one high molecular weight silicone component having a molecular weight between about 100,000 Da and 100,000,000 Da, and at least one analgesic component, wherein the composition is substantially anhydrous, greaseless, and substantially clear or translucent.
2 . The greaseless analgesic composition of claim 1 wherein the high molecular weight silicone component is selected from the group consisting of a dimethicone crosspolymer and a dimethicone gum.
3 . The greaseless analgesic composition of claim 1 wherein said at least one analgesic component is selected from the group consisting of: methyl salicylate, salicylic acid, a salicylic acid derivative, camphor, menthol, eucalyptus oil, capsaicin, histamine dihydrochloride, methyl micotinate, wintergreen extract, eucalyptus extract, turpentine extract, a pharmaceutically acceptable salt of lidocaine, a pharmaceutically acceptable salt of bupivacaine, a pharmaceutically acceptable salt of chlorprocaine, a pharmaceutically acceptable salt of dibucaine, a pharmaceutically acceptable salt of etidocaine, a pharmaceutically acceptable salt of mepivacaine, a pharmaceutically acceptable salt of tetracaine, a pharmaceutically acceptable salt of dyclonine, a pharmaceutically acceptable salt of hexylcaine, a pharmaceutically acceptable salt of procaine, a pharmaceutically acceptable salt of cocaine, a pharmaceutically acceptable salt of ketamine, a pharmaceutically acceptable salt of pramoxine, a pharmaceutically acceptable salt of methdilizine, a pharmaceutically acceptable salt of trimeprazine, phenol and a steroidal or non-steriodal antiimflammatory agent.
4 . The greaseless analgesic composition of claim 3 wherein said at least one analgesic component is selected from the group consisting of: methyl salicylate, salicylic acid, a salicylic acid derivative, camphor, menthol, eucalyptus oil, and capsaicin.
5 . The greaseless analgesic composition of claim 1 further comprising at least one low molecular weight silicone having a measurable vapor pressure at room temperature.
6 . The greaseless analgesic composition of claim 5 wherein said low molecular weight silicone is selected from the group consisting of a cyclic silicone and a non-cyclic silicone.
7 . The greaseless analgesic composition of claim 6 wherein said low molecular weight silicone comprises a cyclomethicone.
8 . The greaseless analgesic composition of claim 7 wherein said low molecular weight silicone comprises a cyclomethicone selected from the group consisting of octylmethylcyclotetrasiloxane, hexamethylcyclotrisiloxane and decamethylcyclopentasiloxane.
9 . The greaseless analgesic composition of claim 6 wherein said low molecular weight silicone comprises a non-cyclic silicone selected from the group consisting of hexamethyldisiloxane and low molecular weight dimethicone.
10 . The greaseless analgesic composition of claim 1 comprising a high molecular weight dimethicone component, a volatile low molecular weight component, and at least one analgesic component selected from the group consisting of methyl salicylate, salicylic acid, a salicylic acid derivative, camphor, menthol, eucalyptus oil and capsaicin.
11 . The greaseless analgesic composition of claim 10 comprising at least two analgesic components selected from the group consisting of methyl salicylate, salicylic acid, a salicylic acid derivative, camphor, menthol, eucalyptus oil and capsaicin.
12 . The greaseless analgesic composition of claim 1 comprising a capsaicin component dissolved in a alkyl fluid.
13 . The greaseless analgesic composition of claim 12 comprising at least one low molecular weight silicone component.
14 . The greaseless analgesic composition of claim 1 , in the form of a serum having a viscosity of from about 0.1 centistokes to about 3500 centistokes.
15 . A method of reducing pain in a mammal, comprising applying to a skin surface of said mammal a composition comprising the composition of claim 1 , and permitting said applied composition to dry on said skin surface, wherein said high molecular weight silicone component forms a substantially clear, water-resistant barrier on said skin surface after drying.
16 . A topical analgesic composition comprising at least one high molecular weight dimethicone component having a molecular weight between about 100,000 Da and 100,000,000 Da, and at least one analgesic component comprising an agent selected from the group consisting of selected from the group consisting of: methyl salicylate, salicylic acid, a salicylic acid derivative, camphor, menthol, eucalyptus oil, and capsaicin, wherein the composition is substantially anhydrous, greaseless, and substantially clear or translucent.
17 . The composition of claim 16 wherein the composition further comprises at least one organic solvent.
18 . The composition of claim 17 wherein the organic solvent comprises an isoparaffinic solvent.
19 . The composition of claim 16 wherein the composition comprises a low molecular weight silicone having a measurable vapor pressure at room temperature.
20 . The composition of claim 17 wherein the composition comprises a low molecular weight silicone having a measurable vapor pressure at room temperature.Join the waitlist — get patent alerts
Track US2014018328A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.